USPTO serial 50052138
ONEAAV
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with ONEAAV?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, Deluca, & Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal preparations for medical, pharmaceutical or veterinary use for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Chemical reagents for medical purposes; Chemical reagents for veterinary purposes; Biological reagents for medical purposes; Biological reagents for veterinary purposes; Biological preparations for use in cell cultures for medical purposes; Therapeutic biological preparations for use in targeted medical and clinical gene therapy, namely, for ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Pharmaceutical preparations for gene therapy for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Pharmaceutical preparations for cellular therapy for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Therapeutic biological preparations for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 042 | Research and development in the field of biotechnology and targeted gene therapy; Biological research in the field of targeted gene therapy systems and nucleic acid delivery systems; Pharmaceutical research and development; Biomedical research in the field of targeted gene therapy systems and nucleic acid delivery systems; Pharmaceutical research in the field of targeted gene therapy systems and nucleic acid delivery systems | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 14, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 14, 2026 | NWAP | NEW APPLICATION ENTERED | — |